- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.11 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.2: 5 residues within 4Å:- Chain A: W.147, G.151, F.152, P.153, K.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.154
EPE.5: 5 residues within 4Å:- Chain B: W.147, G.151, F.152, P.153, K.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.154
EPE.8: 5 residues within 4Å:- Chain C: W.147, G.151, F.152, P.153, K.154
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.154
EPE.12: 4 residues within 4Å:- Chain D: A.97, R.98, E.103, R.111
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:R.98
- Salt bridges: D:E.103, D:E.103, D:R.111
- 4 x W31: (1S)-1-phenylethyl (4-chloro-3-{[(4S)-4-(2,6-dichlorophenyl)-2-hydroxy-6-oxocyclohex-1-en-1-yl]sulfanyl}phenyl)acetate(Non-covalent)
W31.3: 16 residues within 4Å:- Chain A: R.105, L.108, N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAI.1
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:R.105, A:L.108, A:N.137, A:V.234, A:A.237, A:Y.238, A:I.241, A:T.247
- Hydrogen bonds: A:N.137, A:R.168, A:R.168, A:H.192, A:D.194
- Water bridges: A:R.105
- Salt bridges: A:R.105
- pi-Cation interactions: A:R.105
W31.6: 16 residues within 4Å:- Chain B: R.105, L.108, N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAI.4
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:L.108, B:A.237, B:Y.238, B:T.247
- Hydrogen bonds: B:N.137, B:R.168, B:R.168, B:H.192, B:D.194, B:T.247
- Water bridges: B:R.105
- Salt bridges: B:R.105
- pi-Cation interactions: B:R.105
W31.9: 13 residues within 4Å:- Chain C: N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAI.7
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:N.137, C:V.234, C:A.237, C:Y.238, C:T.247
- Hydrogen bonds: C:N.137, C:R.168, C:R.168, C:H.192, C:D.194, C:Y.238
- Water bridges: C:D.194
W31.11: 15 residues within 4Å:- Chain D: Q.99, L.108, N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.233, A.237, Y.238, I.241, T.247
- Ligands: NAI.10
13 PLIP interactions:13 interactions with chain D- Hydrophobic interactions: D:L.108, D:N.137, D:A.237, D:Y.238, D:I.241, D:T.247
- Hydrogen bonds: D:N.137, D:R.168, D:R.168, D:H.192, D:D.194, D:Y.238, D:T.247
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Labadie, S. et al., Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-12-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.11 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 4 x W31: (1S)-1-phenylethyl (4-chloro-3-{[(4S)-4-(2,6-dichlorophenyl)-2-hydroxy-6-oxocyclohex-1-en-1-yl]sulfanyl}phenyl)acetate(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Labadie, S. et al., Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-12-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D